Press Releases

Date	Title	PDF Version
Mar 24, 2020	Alexion Statement on SOLIRIS® (eculizumab) and COVID-19
Mar 05, 2020	Alexion Announces Upcoming Data Presentations at 72nd Annual Meeting of the American Academy of Neurology
Feb 27, 2020	Alexion Announces Launch of Alexion Charitable Foundation and Calls for Grantees
Feb 26, 2020	Alexion to Present at the 40th Annual Cowen Health Care Conference
Feb 20, 2020	Alexion to Present at the 9th Annual SVB Leerink Global Healthcare Conference
Jan 30, 2020	Alexion Reports Fourth Quarter and Full Year 2019 Results
Jan 28, 2020	Alexion Completes Acquisition of Achillion
Jan 24, 2020	UPDATED TIME: Alexion Fourth Quarter and Full Year 2019 Results Conference Call at 7:30am ET on Thursday, January 30, 2020
Jan 17, 2020	Alexion to Report Fourth Quarter and Full Year 2019 Results on Thursday, January 30, 2020
Jan 14, 2020	Alexion Announces Planned Initiation of Pivotal Phase 3 Study of ULTOMIRIS® (ravulizumab) in ALS

Search